ABSTRACT
The ability to sense and respond rapidly to the dynamic environment of the upper respiratory tract (URT) makes Streptococcus pneumoniae (Spn) a highly successful human pathogen. Two-component systems (TCSs) of Spn sense and respond to multiple signals it encounters allowing Spn to adapt and thrive in various host sites. Spn TCS have been implicated in their ability to promote pneumococcal colonization of the URT and virulence. As the disease state can be a dead-end for a pathogen, we considered whether TCS would contribute to pneumococcal transmission. Herein, we determined the role of YesMN, an understudied TCS of Spn, and observe that YesMN contributes toward pneumococcal shedding and transmission but is not essential for colonization. The YesMN regulon includes genes involved in zinc homeostasis and glycan metabolism, which are upregulated during reduced zinc availability in a YesMN-dependent fashion. Thus, we identified the YesMN regulon and a potential molecular signal it senses that lead to the activation of genes involved in zinc homeostasis and glycan metabolism. Furthermore, in contrast to Spn monoinfection, we demonstrate that YesMN is critical for high pneumococcal density in the URT during influenza A virus (IAV) coinfection. We attribute reduced colonization of the yesMN mutant possibly due to increased association with and clearance by the mucus covering the URT epithelial surface. Thus, our results highlight the dynamic interactions that occur between Spn and IAV in the URT, and the role that TCSs play in modulation of these interactions.
KEYWORDS: Streptococcus pneumoniae, transmission, animal models, coinfection, influenza, two-component regulatory systems
INTRODUCTION
The nasopharynx is the initial site of acquisition and the primary reservoir of the human-adapted extracellular respiratory pathogen Streptococcus pneumoniae (Spn; the pneumococcus). Spn resides in the mucosal surface of the upper respiratory tract (URT), and carriage is typically asymptomatic. From this niche in the URT, pneumococcus can spread to another host or cause disease within the same host. Disease states associated with Spn include pneumonia, septicemia, otitis media, and meningitis. Invasive pneumococcal disease is associated with over a million deaths worldwide (1–3).
The ability to colonize and thrive in different host environments is a hallmark of Spn pathogenesis. Multiple studies have shown that pneumococcus modifies its global gene expression depending on the colonization site (4–7). Adapting and responding to the dynamic environments that bacterial pathogens encounter requires rapid responses, some of which are mediated through two-component signal transduction systems (TCSs). Bacterial TCSs generally consist of two proteins, a histidine kinase (HK) that senses external stimuli, and a response regulator (RR). Upon autophosphorylation of the HK in response to external stimuli, the phosphate group is transferred to the RR, which undergoes a conformation change allowing it to act as a regulator (8, 9).
The Spn genome encodes 13 TCSs, each consisting of an HK and a cognate RR, and one orphan response regulator (8, 10). As with other bacterial pathogens, several of these TCSs contribute to pneumococcal colonization and virulence. They sense a variety of signals, including, but not limited to, reactive oxygen species, oxidative stress, antibiotics, antimicrobial peptides, pH, and temperature. In response, they modulate the expression of genes involved in reducing oxidative stress, uptake of nutrients, carbon metabolism, modulating competence and fratricide, releasing bacteriocins, and other factors that affect host-pathogen interactions (8, 10, 11). Several TCSs of Spn have been extensively characterized, including BlpRH, ComDE, and CiaRH. BlpRH is involved in quorum sensing and bacteriocin production; ComDE, through quorum sensing, regulates Spn transformation machinery under specific environmental conditions; CiaRH regulates expression of the serine protease HtrA and the stress response machinery, and negatively influences competence (8, 12). Furthermore, there is cross talk signaling between pneumococcal TCSs, where they respond to the same environmental signal (ComDE and CiaRH both respond to acid stress) and regulate the expression of each other (12–14).
Specific pneumococcal factors, such as pneumolysin (15), dlt locus-dependent d-alanylation of Spn teichoic acid (16), and the type and amount of Spn capsular polysaccharide (17), are essential for Spn host-to-host transmission. These factors modulate the host inflammatory response or the dynamic interactions with mucus protecting the URT epithelial layer. Recent high-throughput transposon mutagenesis (Tn-seq) screens have identified Spn factors important for colonization, virulence, and host-to-host transmission (16, 18, 19). As TCSs can regulate hundreds of genes, it was not surprising that they would be identified in these screens to contribute toward pneumococcal pathogenesis. However, one of the least characterized TCSs, YesMN (also called TCS07), was found to contribute toward pneumococcal host-to-host transmission in two dissimilar Tn-seq approaches with different animal models (16, 19), indicating that YesMN regulates factors that are important determinants of pneumococcal spread.
The putative regulon of YesMN was initially identified by overexpressing YesN (RR) and performing next-generation RNA sequencing (20). Genes involved in host-derived glycan metabolism and transport were among the YesMN regulon. Specifically, genes encoding enzymes for N-glycan metabolism and transport were identified to be upregulated in a YesMN-dependent manner (20). These results were unsurprising, as free carbon is scarce in the URT (21). Spn devotes considerable resources to acquiring carbon by cleaving host glycans, such as heavily glycosylated mucin proteins that form the mucus layer (22, 23). Nevertheless, the signal and the biological relevance in the nasopharynx of YesMN remain poorly defined.
Herein we aimed to validate, using our infant mouse pneumococcal challenge model, the in vivo role of YesMN suggested by Tn-seq screens (16, 18) with a yesMN deletion mutant tested outside the context of a mixed infection. In addition, we sought to better define the YesMN regulon using a yesMN deletion strain rather than overexpression. Our results indicate that YesMN does indeed play a role in transmission but not in URT colonization. Transcriptomic analysis revealed the YesMN regulon includes zinc (Zn2+) homeostasis genes and validated the published role in glycan metabolism (20). Importantly, we found that YesMN impacts its regulon in response to changes in zinc levels, suggesting that zinc may be the signal that is sensed by YesMN.
RESULTS
Effect of yesMN deletion on pneumococcal colonization, shedding, and host-to-host transmission.
A transposon mutagenesis screen with a serotype 4 isolate (TIGR4) revealed putative Spn factors that contribute toward pneumococcal nasopharyngeal colonization and shedding (16, 18). A candidate of particular interest was the HK YesM that forms part of the two-component system (TCS) YesMN (TCS07) (Fig. 1A). Overexpression of the response regulator (RR) YesN in D39 (type 2 isolate) leads to an increase in the expression of genes that code for N-linked glycan-metabolizing enzymes. Also, compared to the parental D39, ΔyesMN had a slightly reduced virulence in a lung infection model (20).
FIG 1.

The two-component system YesMN of pneumococcus contributes toward its shedding and host-to-host transmission. A. Schematic representation of the genetic organization of the TCS YesMN of S. pneumoniae with the TIGR4 designation. Adjusted P values for the genes from the Tn-seq screen that identified YesMN as being important for pneumococcal shedding are listed (16), with the solid line representing the gene deletions constructed for the current study. B. The 4-day-old pups were challenged i.n. with the indicated strain, and nasal secretions were collected, and bacterial load was enumerated for 5 days postinfection. Median CFU values for each day are indicated, and each symbol represents the number of CFUs measured from a single pup (n ≥ 5 for each strain tested). Shedding differences between the two strains on a given day were calculated using the Mann-Whitney U test. C. Pups were challenged i.n. at day 4 of age with the indicated construct, and bacterial shedding from nasal secretions were quantified for 5 days postinfection. Violin plots of pooled 5 days of shedding are indicated with median shown in red. Data are from 6 to 10 pups per group. Statistical differences were calculated using the Kruskal-Wallis analysis of variance with Dunn’s posttest. D. Colonization density of the WT, isogenic mutants, and the chromosomally complemented strain in cultures of URT lavage fluids obtained from pups at day 9 of age. Median values are shown. Dotted line represents the limit of detection (LOD). E. Summary of transmission efficiency of the WT, ΔyesMN mutant, and the corrected strain (yesMN+) from colonized index pups at the age of 4 days to naive contact pups in the same litter. The transmission efficiency was determined by the number of contact pups (at a 1:1 ration to index mice) colonized by S. pneumoniae at the age of 14 days. Fisher’s exact test was used to determine the statistical difference between the WT and the ΔyesMN mutant and yesMN+. *, P ≤ 0.05; **, P ≤ 0.01; ****, P ≤ 0.0001; n.s, not significant.
We were particularly intrigued by identifying the yesMN TCS in our shedding screen, as of the 13 pneumococcal TCSs, YesMN regulation is poorly understood (8). Moreover, another in vivo transposon screen to identify putative transmission factors of Spn using a ferret model identified the RR YesN as being necessary for host-to-host transmission (19). To confirm that the TCS YesMN impacts pneumococcal shedding, we constructed mutants with unmarked, in-frame deletion of HK yesM (ΔyesM), the RR yesN (ΔyesN), or both yesMN (ΔyesMN). Deletion of yesMN was not associated with impaired growth (20) and all the constructed mutants in the study grew as wild-type (WT) type 4 isolate (data not shown).
To determine if YesMN contributes toward Spn shedding, we first assessed ΔyesM, which was identified in our shedding screen (16). Shedding was measured daily (days 1 to 5 postinoculation) from the inoculated pups. Compared to the WT type 4 strain, the isogenic mutant ΔyesM shed poorly over 5 days (Fig. 1B). Because of established day-to-day variation (24), daily shedding values were also pooled for comparison (Fig. 1C). The HK (ΔyesM), RR (ΔyesN) mutants, and the complete TCS knockout (ΔyesMN) all showed reduced median shedding compared to either the WT type 4 strain or the corrected mutant (yesMN+ mutant). These results included an intralitter comparison of strains inoculated into pups from multiple litters to control for host and environmental effects on shedding. The contribution of yesMN to shedding was not due to differences in colonization density, as all the strains colonized equally well at the conclusion of the shedding experiment at the age of 9 days (Fig. 1D).
Next, we determined whether reduced shedding attributed to the yesMN mutants manifests as a defect in host-to-host transmission. Using a 1:1 ratio of Spn-inoculated pups (index) to uninoculated littermates (contact pups), ~40% transmission was observed with the WT type 4 strain. In contrast, no transmission events were detected with the ΔyesMN strain. Transmission to WT levels was restored with the corrected strain (yesMN+) (Fig. 1E). Furthermore, all constructs colonized the pups at a high density at the conclusion of the transmission study at the age of 14 days (see Fig. S1 in the supplemental material). Thus, we validated our and others' observations, confirming that under Spn monoinfection, YesMN does not affect colonization but is required for sufficient pneumococcal shedding to allow for host-to-host transmission.
Comparative transcription analysis of YesMN mutant.
Recently, RR yesN overexpression led to the identification of the YesMN regulon (20). As pneumococcal TCSs exist in a balanced cross talk, overexpression of a single RR can potentially affect other signaling pathways. To provide more physiologically relevant molecular testing conditions, we determined the global gene expression patterns in a ΔyesMN strain to identify the putative YesMN regulon. The WT type 4 and the ΔyesMN strains were grown in tryptic soy yeast (TSY) medium, and total RNA transcript abundance was measured using RNA-seq. A total of 137 differentially regulated genes were identified in the ΔyesMN compared to the WT strain (Log2FC>±1, Padj < 0.05), of which 88 were downregulated and 49 were upregulated (Fig. 2A to C) (Table S1). Besides genes of unknown function, most of the genes identified were involved in the uptake of nutrients and their metabolism (Fig. 2B to C). The top downregulated genes encode proteins involved in zinc homeostasis, host-glycan and carbohydrate transport and metabolism, and the locus associated with purine metabolism (Table 1). The putative YesMN regulon included genes previously shown to be necessary for pneumococcal colonization and/or shedding (16, 18). Notably, genes that encode enzymes involved in host-glycan metabolism (Table 1) identified in our RNA-seq analysis were correspondingly identified when YesN was ectopically overexpressed in the D39 background (20). Thus, our RNA-seq results align with the previously described study and identified new members of the YesMN regulon.
FIG 2.

Identification of the genes regulated by the pneumococcal TCS YesMN. The transcriptome of wild-type TIGR4 and the isogenic ΔyesMN mutant was compared through RNA-seq analysis. Strains were grown in TSY to OD620 of ~0.4, RNA isolated, and prepared for analysis as described in Materials and Methods. A. Volcano plot depicting genes whose RNA transcripts were differentially regulated (Log2FC > ±1; P < 0.05). Genes involved in zinc homeostasis are highlighted. B and C. Functional annotation of genes appearing clockwise whose transcripts in the ΔyesMN mutant compared to the wild type were either downregulated (B) or upregulated (C).
TABLE 1.
Major functional classes of genes whose transcripts were downregulated in a ΔyesMN mutanta
| TIGR4 designation | Gene name and description | Function | Log2FC |
|---|---|---|---|
| Manganese and zinc homeostasis | |||
| SP_2136 | pcpA; choline binding protein (CbpN) | Adherence and virulence (79, 80) | −2.87 |
| SP_1002 | adcAII; zinc transport system substrate-binding protein | Colonization and virulence (26, 81) | −2.59 |
| SP_1174 | phtB; histidine triad protein | Adherence and immune evasion (79, 82) | −2.44 |
| SP_1003 | phtD; histidine triad protein | Adherence and immune evasion (79, 82) | −2.08 |
| SP_1004 | phtE; histidine triad protein | Adherence and immune evasion (82, 83) | −1.49 |
| SP_1175 | phtA; histidine triad protein | Adherence and immune evasion (79, 82) | −1.13 |
| SP_1650 | psaA; ABC transporter | Manganese/zinc transport, virulence (84, 85) | −1.23 |
| SP_1648 | psaB; ABC transporter | Manganese/zinc transport, virulence (84) | −1.18 |
| SP_1649 | psaC; ABC transporter | Manganese/zinc transport, virulence (84) | −1.21 |
| Host glycan metabolism | |||
| SP_2143 | GH38; putative exo-α-(1, 3)-mannosidase | Glycan metabolism, colonization, and virulence (18, 31) | −2.07 |
| SP_2144 | GH125; exo-α-(1, 6)-mannosidase | Glycan metabolism and virulence (31, 86) | −1.75 |
| SP_0091 | ngtP1; ABC transporter | Glycan transport (31) | −1.67 |
| SP_0090 | ngtP2; ABC transporter | Glycan transport (31) | −1.63 |
| SP_0092 | ngtS; ABC transporter | Glycan transport and virulence (44) | −1.61 |
| SP_2142 | ROK; putative sugar kinase | Glycan metabolism and virulence (31, 44, 86) | −1.55 |
| SP_2141 | GH20C; exo-β-hexosaminidase | Glycan metabolism (31) | −1.43 |
| SP_0498 | endoD; (GH85); N-glycan endo-β-N-acetylglucosaminidase | Glycan metabolism and virulence (31, 44, 87) | −1.14 |
| Carbohydrate metabolism | |||
| SP_2021 | 6-Phospho-β-glucosidase | Putative cellobiase (25) | −1.16 |
| SP_2022 | Phosphotransferase system | Cellobiose-specific IIC component and virulence (25, 44) | −1.15 |
| SP_0308 | Phosphotransferase system | Cellobiose-specific component IIA (25) | −1.12 |
| SP_2023 | Phosphotransferase system | Cellobiose-specific IIB component (25) | −1.09 |
| SP_2024 | Phosphotransferase system | Cellobiose-specific IIA (25) | −1.09 |
| SP_0307 | Hypothetical protein | −1.08 | |
| Purine biosynthesis | |||
| SP_0044 | purC | Purine biosynthesis (88, 89) | −2.71 |
| SP_0052 | Hypothetical protein | −2.37 | |
| SP_0045 | purL; putative phosphor-ribo-sylformyl-glycinamidine synthase | Purine biosynthesis and Virulence (44) | −2.33 |
| SP_0051 | purD | Purine biosynthesis | −2.32 |
| SP_0053 | purE; 5-(carboxyamino)imidazole ribonucleotide mutase | Purine biosynthesis | −2.17 |
| SP_0046 | purF; amidophosphoribosyltransferase | Purine biosynthesis | −2.13 |
| SP_0047 | purM; phosphoribosylformylglycinamide cyclo-ligase | Purine biosynthesis | −2.11 |
| SP_0048 | purN; phosphoribosylglycinamide formyltransferase | Purine biosynthesis | −2.04 |
| SP_0054 | purK; 5-(carboxyamino)imidazole ribonucleotide synthase | Purine biosynthesis | −2.02 |
| SP_0049 | vanZ; hypothetical protein | Virulence (44) | −1.95 |
| SP_0050 | purH; phosphoribosylaminoimidazolecarboxamide formyltransferase | Purine biosynthesis and virulence (44) | −1.32 |
Gene name, description, and function were based on information retrieved from KEGG and UniProt databases and literature searches.
Examination of the upstream region of the genes that form the YesMN regulon did not yield a consensus binding site for the RR07, suggesting further analysis is required to identify a putative consensus binding site. Furthermore, CiaR that forms the part of the CiaRH TCS and several of its regulon members were in the list of genes whose transcripts were upregulated (~2-fold) in the ΔyesMN strain (Table S1), indicating cross-regulation of pneumococcal TCS. In addition, the highly conserved fruRBA operon (25) involved in fructose uptake and metabolism was also upregulated. Taken together, our RNA-seq analysis provides a global view of the YesMN regulon. Herein, we focused on genes involved in N-glycan metabolism and zinc homeostasis as these were part of the most underrepresented genes/pathways identified in our screen.
To validate the results from the RNA-seq analysis, quantitative real-time PCR (qRT-PCR) was performed targeting 11 specific genes implicated in either zinc homeostasis or host-glycan metabolism (Table 1; Fig. 3). Neuraminidase A (nanA) and B (nanB) were selected as controls, as they were not identified by the RNA-seq screen to be modulated by YesMN. The YesMN-regulated genes to be validated included adcAII, which encodes an adhesion lipoprotein with specificity for Zn2+ (26); and phtD and phtE, known as pneumococcal histidine triad (Pht) proteins that form an operon with adcaII. Pht family proteins are also involved in Zn2+ acquisition, and upregulated under low Zn2+ (27, 28). pcpA, which encodes choline-binding protein N that acts as an adhesin (29), was also observed in the RNA-seq screen to be regulated by YesMN. However, in the presence of Mn2+, PsaR, a metal-dependent regulator, negatively regulates the expression of several genes, including pcpA (30). Besides genes involved in Zn2+ homeostasis, we tested endoD, GH20C, ROK, GH38, and GH125, which are involved in N-glycan metabolism (20, 31). We observed a statistically significant ~2-fold reduction in the transcripts of the selected genes when comparing ΔyesMN to the WT strain (Fig. 3A and B). No reduction was observed in the transcripts of control genes (nanA and nanB) that do not belong to the YesMN regulon (Fig. 3A). Taken together, our results strongly suggest that YesMN regulates genes involved in zinc homeostasis and glycan metabolism.
FIG 3.

YesMN regulates genes involved in zinc homeostasis and glycan metabolism. Differential gene expression in ΔyesMN of selected genes by quantitative real-time PCR (qRT-PCR). WT and the ΔyesMN isogenic mutant were grown to OD620 of ~0.4 in TSY broth at 37°C, RNA isolated, and prepared for qRT-PCR analysis. Shown is fold change in transcription of genes between WT and ΔyesMN involved either in (A) zinc homeostasis or (B) glycan metabolism. nanA and nanB that are not part of the YesMN regulon were tested as controls (gray bars). TIGR4 16s (rrsA, SP_0775) specific primers were used as the housekeeping gene for 2–ΔΔCt analysis. For each biological replicate (n ≥ 3 for WT and ΔyesMN), qRT-PCR was conducted in triplicate. Bars represent mean ± SEM. Statistical differences between the WT and the yesMN mutant were calculated using the Mann-Whitney U test. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001.
YesMN appears to respond to Zn2+ levels to modulate its regulon.
Based on our RNA-seq analysis that identified genes involved in Zn2+ homeostasis belonging to the YesMN regulon, we hypothesized that YesMN responds to Zn2+ levels in the environment. Previously, adcaII and pht gene transcripts were found to be upregulated when grown in N, N, N′, N′-tetrakis-(2-pyridylmethyl)-ethylene-diamine (TPEN), a membrane-permeable zinc chelator (32). Correspondingly, the TSY-growing WT strain, when shifted to TSY containing 30 μM TPEN, led to an upregulation in the transcript levels of the adcaII and pht genes, as well as pcpA (~15- to 30-fold) (Fig. 4A). In addition, transcripts of glycan metabolism genes were upregulated (Fig. 4B), albeit less (~2- to 4-fold) than the zinc homeostasis genes. In contrast, in the ΔyesMN strain, TPEN treatment did not increase the transcripts of genes involved in zinc homeostasis or glycan metabolism to the same level as WT (Fig. 4A and B). Zinc homeostasis genes were still upregulated (~3- to 4-fold) in the ΔyesMN strain under TPEN, suggesting that other factors also contribute to the increase in expression of these genes under reduced levels of Zn2+. Collectively, our data suggest that the Zn2+ homeostasis and glycan metabolism genes form part of the YesMN regulon and respond to reduced Zn2+ levels.
FIG 4.

YesMN responds to reduced availability of zinc. Quantitative real-time PCR analysis was used to examine gene expression in the WT and the ΔyesMN isogenic mutant in response to zinc chelation. Strains were grown to an OD620 of ~0.4 in TSY broth at 37°C. Half of the culture was transferred to a clean tube and treated with TPEN and the other half remained untreated; these were grown for an additional 30 min at 37°C. RNA was isolated and prepared for qRT-PCR analysis as described in the Materials and Methods. TIGR4 16s (rrsA, SP_0775)-specific primers were used as the housekeeping gene for 2–ΔΔCt analysis. Bars (mean ± SEM) in red represent WT whereas gray bars represent ΔyesMN and indicate the fold change in transcript abundance between treated (TPEN) or untreated zinc homeostasis genes (A) or glycan metabolism genes (B). For each biological replicate (n ≥ 3 for WT and ΔyesMN), qRT-PCR was conducted in triplicate. Statistical differences between the WT and the ΔyesMN mutant were calculated using the Mann-Whitney U test. **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001.
YesMN is required for robust colonization during concurrent influenza A infection.
Epidemiological data show that bacterial-influenza A virus (IAV) coinfections occur in more than 30% of all IAV cases, predominantly with pneumococcus (33, 34). These coinfections are associated with increased morbidity and mortality (35, 36). Spn-IAV coinfection alters the nasopharyngeal landscape of the infected host, with an increase in inflammation and mucus production, allowing Spn to proliferate further (37–39). Recently, a transposon mutagenesis screen using a type 3 isolate identified Spn factors important for nasopharyngeal colonization with a concurrent IAV infection. The list of genes identified included several that form part of the YesMN regulon and are involved in N-glycan metabolism (40). We hypothesized that even though the ΔyesMN strain colonizes as WT under monoinfection, its regulon members are potentially critical for colonization during IAV coinfection.
To test our hypothesis, we inoculated pups with either the ΔyesMN strain or the WT type 4 isolate at 4 days of life and, on day 9, gave them the mouse-adapted influenza A virus/Puerto Rico/8/34(H1N1), here referred to as “PR8,” and followed the modulation of Spn shedding from the pups over 5 days post-IAV infection. Analogous to our previous studies, the WT strain shed at a high level during IAV coinfection (24). Like the results for monoinfection (Fig. 1C), the ΔyesMN strain also had a defect in shedding during IAV coinfection (Fig. 5A). However, unlike monoinfection, where the ΔyesMN strain colonized as WT (Fig. S1), with a concurrent IAV infection, the mutant colonized poorly (Fig. 5B), suggesting that the YesMN regulon promotes robust colonization in the shifting landscape of the nasopharynx. Furthermore, the shedding and colonization defect was YesMN specific as the yesMN+ strain shed and colonized as WT. Thus, our data show that even though YesMN is dispensable during monoinfection, it is critical for pneumococcal colonization during an IAV coinfection and provides further evidence that Spn-IAV interactions are not necessarily synergistic in the upper respiratory tract.
FIG 5.

YesMN is required for robust pneumococcal shedding and colonization in the setting of influenza A virus coinfection. A. Four-day old pups were challenged i.n. with either the WT, the isogenic yesMN mutant, or the corrected yesMN+ strain. Five days later, pups were challenged with influenza A virus, and pneumococcal shedding in nasal secretions was quantified daily for 5 days. Pooled median shedding values of 5 days are shown, where each symbol represents CFU values obtained from a single pup. B. Colonization density of each pneumococcal construct in cultures of URT lavage fluids obtained from pups at day 14 of age. Median values are shown. Dotted line represents the LOD. Data are from 8 to 11 pups per group. Statistical differences were calculated using the Kruskal-Wallis analysis of variance with Dunn’s posttest. *, P ≤ 0.05; **, P ≤ 0.01; n.s, not significant.
YesMN impacts the interaction of pneumococcus with human nasal fluid.
The YesMN regulon includes genes that encode proteins that act as adhesins, promote virulence, and contribute toward N-linked glycan metabolism (Table 1). Previous studies demonstrated that high pneumococcal shedding is dependent upon (i) ability of Spn to cause a robust inflammatory response in the URT that results in an increase in nasal secretions, and (ii) its ability to escape mucus present on the URT epithelial surface (15, 17, 37, 41, 42). We therefore examined whether the reduced shedding from the URT of the ΔyesMN strain during mono-infection is due to reduced inflammation. The chemokines (CXCL-1, CXCL-2) and cytokine interleukin-1β (IL-1β) are considered hallmarks for Spn-induced inflammation in the URT (15), and their levels were measured following inoculation with WT or the yesMN mutant. At 2 days postinoculation, we did not observe upregulation of these inflammatory markers in mice inoculated with either strain. (Fig. S2). Thus, our qRT-PCR data likely precludes Spn-mediated inflammatory response in the URT as the basis for reduced shedding associated with the ΔyesMN mutant.
Based on our observation, we postulated that an increase in nasal secretions leads to a reduced load of the ΔyesMN mutant in URT during coinfection. To determine whether YesMN contributes to interactions with mucus, we performed a previously described in vitro solid-phase human mucus binding assay using pooled human nasal fluid (hNF) (43). Adherence of the ΔyesMN strain to mucus was significantly higher than the WT type 4 isolate, suggesting that YesMN regulates pneumococcal factors that promote mucus evasion (Fig. 6). This enhanced adherence was not because of reduced capsular polysaccharide (CPS), as both the mutant and the WT strain made similar levels of CPS (Fig. S3). Moreover, this enhanced interaction with hNF was specific to the ΔyesMN mutant, as the yesMN+ strain restored reduced interaction with hNF. Overall, our results demonstrate that YesMN-regulated factors influence interactions with the components that constitute hNF.
FIG 6.

YesMN affects human nasal fluid association. Comparison of binding level of WT, the ΔyesMN, and the yesMN+ strains to immobilized human nasal fluid (hNF). A total of 10 μg of hNF in 100 μL was immobilized in a 96-well micotiter plate overnight and then blocked with 0.1% BSA. After gentle washing, bacteria (2× 104 CFU/100 μL DMEM) were added, and the plate was incubated for 2 h at 30°C. After 19 washes, adherent bacteria were determined by resuspending with 0.001% Triton X-100 following plating on TSY agar plates supplemented with 200 μg/mL streptomycin. Values are means of three independent determinations in triplicate ± SEM. Statistical differences were calculated using the Kruskal-Wallis analysis of variance with Dunn’s posttest. **, P < 0.01; ***, P < 0.001; n.s, not significant.
DISCUSSION
In the current study, we sought to increase our understanding of nasopharyngeal colonization and host-to-host transmission of the human-adapted pathogen Streptococcus pneumoniae using an infant mouse model (24). Two-component systems respond to various overlapping signals that allow for quick adaptation and establishment by Spn within the nutrient-poor but dynamic environment of the nasopharynx (8). Two independent Tn-seq screens identified one of the least characterized TCSs (YesMN) as contributing to the spread of Spn from one host to another without impacting its colonization of the URT (16, 19). Thus, to provide a molecular understanding of how YesMN promotes pneumococcal spread, we identified its regulon members and the signal it uses to modulate their expression.
Previous studies with adult mice demonstrated that YesMN impacted pneumococcal virulence (20, 44, 45). Our tractable infant mouse model allowed us to examine the contribution of YesMN in pneumococcal colonization, shedding, and host-to-host transmission. YesMN knockout strains had reduced shedding without impacting colonization (Fig. 1). Consequently, we determined whether YesMN impacts Spn host-to-host transmission, as our previous work had shown that reduced shedding correlates with poor transmission dynamics (15). Our transmission studies demonstrated that a ΔyesMN strain is unable to transmit, providing further evidence that reduced shedding impacts transmissibility, and highlights the importance of YesMN to pneumococcal spread to another host. Hence, our data established that YesMN-coordinated regulation of the genes in the nasopharynx is likely critical for robust Spn shedding and transmission.
To gain insight into the genes within the YesMN regulon that could influence the virulence and transmission phenotypes, we performed RNA-seq with a serotype 4 WT (TIGR4) and isogenic ΔyesMN strains. We observed that transcripts of genes involved in Zn2+ homeostasis, N-linked glycan metabolism, carbohydrate metabolism, and purine metabolism were downregulated in the ΔyesMN strain (Table 1). This data aligns well with the transcript changes published by Andreassen et al. (20) using the genetically distinct D39 strain (serotype 2). Although Spn isolates are genetically diverse with over 90 serotypes, the genes within the YesMN regulon are conserved across Spn isolates (11, 20). Even with this genetic regulon conservation, it is possible that there are small genetic differences between the two isolates tested. An important caveat to this study is that the RNA-seq was performed on bacteria grown in TSY, which is likely to be nutritionally dissimilar to the nasopharyngeal environment. However, several of the genes identified in this in vitro screen have been previously identified as essential for either colonization or shedding (16, 18, 44), suggesting that the TSY growth medium is not inappropriate for such analyses.
In our RNA-seq analysis, we identified genes that are involved in zinc homeostasis, which we verified through subsequent qRT-PCR and illustrated that YesMN contributes under Zn2+ chelation conditions to the upregulation of zinc homeostasis and glycan metabolism genes. Trace metals, including zinc, are critical for the enzymatic function of both eukaryotic and prokaryotic cells (46). Zinc deficiency, modeled in murine and human studies, is associated with the reduced phagocytic activity of polymorphonuclear (PMN) cells and degradation of the mucus layer, which leads to increased disease severity and bacterial burden (47–52). Likewise, an increase in dietary zinc is concomitant with a reduction in invasive pneumococcal disease (53–55).
In keeping with the critical role of zinc, the host modulates Zn2+ levels in the blood and respiratory tract in response to pneumococcal infection (nutritional immunity) (50, 56). In this dynamic microniche environment where Zn2+ concentrations can fluctuate, Spn must strike a delicate balance between Zn2+ sufficiency and toxicity, maintained by Zn2+ homeostasis genes (56–59). The URT is a nutritionally poor environment with low levels of Zn2+ where the host mucin proteins, which contain labile Zn2+, potentially serve as a source (60, 61). Correspondingly, Ogunniyi et al. (62) observed an upregulation in the URT, relative to in vitro, of the transcripts of the histidine triad proteins (pht). These proteins, together with AdcA and AdcaII, are required for zinc uptake (26, 28).
The HK YesM is predicted to contain a large extracellular loop allowing it to detect small molecules and ions and providing it potentially with the ability to respond to a diverse number of signals (8). Interestingly, when we used TPEN, a high-affinity chelator of Zn2+, to mimic the zinc starvation that Spn likely encounters in the URT, we observed a YesMN-dependent regulation of the pht, adcaII, and glycan metabolism genes (Fig. 4A and B). Thus, our data suggest that YesMN coordinates the expression of these genes, resulting in enhanced shedding and subsequent transmission of Spn. Surprisingly, we identified pcpA to be a member of the YesMN regulon. In contrast to the adcaII and the pht genes, whose transcripts are upregulated under reduced Zn2+ levels in the environment, pcpA expression is regulated by CodY (63) and PsaR (30). PsaR regulatory roles are dependent on divalent ion concentration. High levels of Mn2+ cause downregulation, whereas high levels of Zn2+ lead to upregulation of pcpA (64). Generally, there are higher levels of Mn2+ in the nasopharynx compared to Zn2+ (30, 64); therefore, PsaR would likely downregulate the expression of pcpA. However, pcpA expression in the URT is higher than the blood (4), and functional antibodies have been observed in children without local or systemic infection (65), suggesting that pcpA is expressed in the URT. The opposing role of PsaR and YesMN would suggest the essentiality of pcpA expression under specific conditions, and that YesMN under reduced levels of Zn2+ might override the downregulation of pcpA by PsaR.
As Spn-IAV coinfections occur frequently and can result in higher morbidity and mortality (35, 36), we investigated the role of YesMN during Spn-IAV coinfection of the nasopharynx. Similar to Spn monoinfection, we observed reduced Spn shedding from pups colonized with the ΔyesMN mutant (Fig. 5A). However, in contrast to monoinfection, pups colonized with the ΔyesMN mutant coinfected with IAV had a defect in URT colonization (Fig. 5B). During Spn-IAV coinfection, Spn shedding and URT colonization density is known to increase over time, which has been attributed to an increase in nasal secretions and reduced mucociliary action (37, 38, 66). Moreover, increased Spn shedding leads to an increase in host-to-host transmission (38). These data suggest that Spn-IAV coinfection is beneficial for Spn dissemination. However, Spn impacts IAV titers and host-to-host transmission negatively (67, 68). Furthermore, IAV infection leads to the dispersal of Spn biofilms and modulation of its transcriptome (69). Collectively, these data suggest a complex, possibly antagonistic relationship, where IAV infection changes the nasopharyngeal landscape, to which Spn has to respond dynamically. Our results further build on these data, where the YesMN regulon provides Spn with an advantage in the dynamic environment of the URT during Spn-IAV coinfection, where N-glycan metabolism and other sugars cleaved from glycoconjugates for metabolism possibly allows for an increase in Spn density in the nasopharynx. Additionally, our hNF binding assay suggests that YesMN-regulated factors contribute toward the ability to escape nasal secretion and not be cleared by the host. Thus, it is likely that YesMN-dependent changes in gene expression allow Spn to navigate the inflamed URT, where N-linked glycan metabolism and other factors allow Spn to thrive and escape in high numbers to transmit to another host, although we cannot rule out other effects of YesMN-dependent factors involved in N-linked glycan metabolism, such as providing a carbon source as a nutrient for growth.
In conclusion, our studies have enhanced our understanding of one of the least characterized TCSs of S. pneumoniae. We demonstrate that YesMN contributes toward Spn shedding and host-to-host transmission during pneumococcal monoinfection. We attribute reduced shedding of the ΔyesMN mutant to an inability to escape the mucus that lines the epithelial layer of the URT, suggesting that YesMN encodes factors critical for Spn-mucus interactions. These YesMN-dependent factors include surface proteins required for zinc homeostasis and glycan metabolism. Furthermore, we provide evidence for antagonistic interaction during Spn-IAV coinfection, where YesMN promotes the ability of Spn to thrive in the inflamed URT cocolonized with IAV. Elucidation of specific YesMN-dependent factors that impact the ability of Spn to persist and thrive in the inflamed URT would provide further mechanistic insights into bacterial colonization and dissemination.
MATERIALS AND METHODS
Ethics statement.
This study was conducted according to the guidelines outlined by National Science Foundation animal welfare requirements and the Public Health Service Policy on Humane Care and Use of Laboratory Animals (70). All animal work was done according to the guidelines provided by the American Association for Laboratory Animal Science (AALAS) (71) and with the approval of the Wake Forest Baptist Medical Center Institutional Animal Care and Use Committee (IACUC). The approved protocol number for this project is A20-057.
Growth conditions and strain construction.
Strains used in the current study are listed in Table 2. Pneumococcal strains were grown at 37°C in tryptic soy broth (Becton, Dickinson [BD]) supplemented with 0.3% yeast extract (TSY). The strains in this study are derivatives of AZ57, which is a streptomycin-resistant derivative of the type 4 strain TIGR4 (24). Once Spn cultures reached the desired optical density at 620 nm (OD620), they were washed, and diluted in sterile phosphate-buffer saline (PBS) for intranasal inoculation and other assays. To quantitate S. pneumoniae, serial dilutions were routinely plated on TSY agar-streptomycin (200 μg/mL), supplemented with either catalase (6,300 U/plate; Worthington Biochemical Corporation) or 5% defibrinated sheep’s blood, and incubated overnight at 37°C with 5% CO2. The yesM, yesMN, and yesN deletion mutants were constructed using the Janus cassette (72) in a two-step process. Briefly, the Janus cassette was amplified from genomic DNA isolated from strain AZ59 (15) using the MasterPure DNA purification kit (Lucigen), with flanking regions (~1 kb) upstream and downstream of the gene of interest using isothermal assembly. Strain AZ57 was then transformed with the PCR product and the transformants selected on TSY agar with kanamycin (125 μg/mL). The resulting mutant was confirmed through PCR and selected for making an in-frame clean gene deletion. The mutant was transformed with PCR product using the primers listed in Table S2 in the supplemental material. All in-frame clean gene deletions contain the first and last 5 amino acid coding sequence of the gene of interest. The corrected mutant yesMN+ was constructed using primers (YesMN-US-1/YesMN-DS-6) on genomic DNA from AZ57, and the resultant PCR product was transformed into strain AZ83; transformants selected on TSY agar-streptomycin (200 μg/mL). We performe qRT-PCR (described below) to rule out potential downstream polar effects of the gene deletions. Comparing transcript levels of the genes immediately downstream of yesMN did not identify any differences between the WT and the ΔyesMN strain, suggesting the deletion of yesMN did not impact transcription (Fig. S4).
TABLE 2.
Strains used in the study
| Strain | Descriptiona | Reference or source |
|---|---|---|
| AZ57 | P2406; (TIGR4SmR) | 24 |
| AZ59 | P2423; TIGR4 ply::kan-rpsL+; KmR, SmS | 15 |
| AZ69 | AZ57; yesM::kan-rpsL+; KmR, SmS | This study |
| AZ81 | AZ69; ΔyesM; SmR | This study |
| AZ83 | AZ57; yesMN::kan-rpsL+; KmR, SmS | This study |
| AZ84 | AZ83; ΔyesMN; SmR | This study |
| AZ85 | AZ57; yesN::kan-rpsL+; KmR, SmS | This study |
| AZ86 | AZ86; ΔyesN; SmS | This study |
| AZ88 | AZ83; yesMN+, SmR | This study |
Km, kanamycin; Sm, streptomycin.
Infant mouse infection model for shedding, colonization, and transmission.
All mouse studies were performed with C57BL/6J specific pathogen-free (SPF) mice that were initially obtained from the Jackson Laboratory (Bar Harbor, ME), then bred and maintained in the animal facility at Biotech Place, Wake Forest Baptist Medical Center. The pups were housed with their dam (mother) for the duration of the study and gained weight like uninfected animals.
Pups were infected as described previously (24). Briefly, at day 4 of life, the pups were inoculated intranasally (i.n.) with ~2,000 CFU of S. pneumoniae suspended in 3 μL of PBS. Postinoculation, shedding was determined by gently tapping the nares of pups (20 taps per pup) on to a TSY agar plate supplemented with either streptomycin (200 μg/mL) or kanamycin (125 μg/mL) to only allow for the growth of Spn. The nasal secretions were spread using a sterile cotton-tipped swab, and the plates were incubated as described above. Because of inherent variability in shedding from day-to-day, the CFU values obtained from individual pups were pooled for the 5-day duration of the study. To control for environmental and microbiome variability, shedding of different strains was compared for pups within the same litter. The mouse-adapted influenza A virus PR8 was used for coinfection studies. Five days postinoculation with Spn, pups were challenged i.n with 2× 104 PFU of PR8 suspended in 3 μL of PBS. Daily shedding was quantified as above, but because of higher shedding values, only 10 taps per pup were carried out.
To determine colonization density, pups were euthanized at the designated time points by CO2 asphyxiation followed by cardiac puncture. The upper respiratory tract (URT) was exposed and lavaged with 200 μL of sterile PBS from a needle inserted into the trachea, and fluid collected from the nares. The limit of detection for Spn in lavage fluid was 33 CFU/mL.
Pneumococcal monoinfection transmission studies were performed as previously described (24). Briefly, at day 4 of life, half of a cohort of pups were randomly selected to be inoculated with the indicated Spn strain. These index mice were then returned to their uninfected littermates (contact pups) and cohoused for 10 days postinoculation. To determine transmission from the index pups, all pups were euthanized at the age of 14 days, and nasal lavage fluid was collected and serially diluted on TSY agar plates supplemented with appropriate antibiotic.
RNA-seq sample preparation and analysis.
Spn cultures were grown as described above to an OD620 of ~0.4, and RNA isolated using the Qiagen AllPrep bacterial DNA/RNA/protein kit following the manufacturer’s protocol. Purified RNA samples were analyzed for quality by electrophoretic tracing (Agilent Bioanalyzer). The Illumina TruSeq Stranded Total RNA LT kit with bacterial Ribo depletion probes (Illumina) were used to construct cDNA libraries from samples with RNA integrity (RIN) values equal to 10. Briefly, 500 ng of total RNA was rRNA depleted, fragmented, reverse-transcribed to cDNA, then purified via AMPure XP magnetic beads. Sequencing adaptors were then ligated to end-repaired fragments, and the libraries were preamplified by PCR and quantified on a Qubit 3.0 (Thermo Fisher, USA). Dual indexed libraries were pooled and sequenced to a target read depth of 50 M reads on an Illumina NextSeq 500 using a 75-bp single-end sequencing and a high-output flow cell. For all samples, >90% of sequences achieved >Q30 Phred quality scores (FASTQC analysis, Babraham Bioinformatics). Contaminating adapters were removed with Trimmomatic (73). Reads were aligned to the genomic reference Streptococcus pneumoniae TIGR4 using Bowtie 2 (74). Gene counts were determined using featureCounts software (75). Differentially expressed genes were identified by negative binomial modeling using DESeq2 (76) with false discovery correction (Benjamini-Hochberg). This work was performed by the Cancer Genomics Shared Resource of the Wake Forest Baptist Comprehensive Cancer Center.
RNA isolation and qRT-PCR.
Host RNA was isolated by lavaging the URT of pups inoculated with Spn or mock inoculated (PBS) at the designated time point using RLT lysis buffer (Qiagen) to obtain RNA from the epithelium. RNA was purified and cDNA generated as per manufacturer’s (Bio-Rad) instructions. qRT-PCR was performed using Bio-Rad SYBR green master mix, ~2.5 ng cDNA, and 0.5 mM primers per reaction mix. Primers directed toward glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were used as an internal control. Samples were run on CFX384 Touch real-time PCR detection system (Bio-Rad) in duplicate, and each run was repeated twice. RNA expression was quantified using the ΔΔCT threshold cycle (CT) method. Primers used in the current study were previously described (77, 78).
qRT-PCR was performed on TSY broth-grown Spn cultures to confirm the genes that form the YesMN regulon. The WT and ΔyesMN strains were grown in TSY broth statically at 37°C until they reached an OD620 of ~0.4 and (2 mL) was spun down at room-temperature at 15,500 × g for 2 min. Samples were treated with RNAprotect bacteria reagent (Qiagen), and RNA was isolated using the AllPrep bacterial DNA/RNA/protein kit (Qiagen) following the manufacturer’s protocol. cDNA and qRT-PCR were carried out as described above with the primer sets listed in Table S3.
To determine the effect of Zn2+ on the expression of YesMN-dependent genes, WT and ΔyesMN were grown statically in TSY broth at 37°C until they reached an OD620 of ~0.3. At that point, samples were divided and either treated with Zn2+-chelating agent TPEN (30 μM) or untreated for 30 min at 37°C. Afterwards, RNA isolation, cDNA synthesis, and qRT-PCR were performed as described above.
Human nasal fluid binding assay.
Adherence of different strains to hNF was assessed using a solid-phase binding assay, as previously described (41, 43). Pooled nasal secretion samples from human volunteers were purchased from LeeBio (Maryland Heights, MO, USA; 991-13-S), sonicated on ice to homogenize samples, and protein amount was determined using the Coomassie Plus protein assay reagent (Thermo Scientific). Briefly, 10 μg total hNF protein (in 100 μL PBS) was immobilized on a 96-well polystyrene plate (Sarstedt REF:82.1581.001) by centrifugation (250 × g) for 3 min at room temperature and incubated overnight at 37°C. Plates were gently washed 3 times with 100 μL DMEM, blocked with 100 μL 0.1% bovine serum albumin (BSA) in DMEM for 2 h, then washed again 3 times with 100 μL DMEM. Spn strains to be tested were grown to an OD620 of ~0.4 in TSY broth and diluted into DMEM to 2× 104 CFU/100 μL, and 100 μL aliquoted into each well. The plate was centrifuged (250 × g for 3 min) and incubated at 30°C with 5% CO2 for 2 h. The wells were then washed 19 times with DMEM, and the adherent bacteria were removed by adding 100 μL of 0.001% Triton X-100-PBS and incubating for 15 min at room temperature followed by vigorous mixing. The samples were then serial diluted and plated on TSY agar plates with antibiotics and incubated overnight at 37°C with 5% CO2. Each strain was tested in triplicate on three different days.
ELISA for quantifying capsular polysaccharide.
A capture ELISA to determine the CPS amount of pneumococcal isolates was performed as described previously (17). Briefly, Immulon 2HB plates (Thermo Scientific) were coated with serotype 4-specific rabbit antiserum (Staten Institut, Denmark) at a dilution of 1:5,000, and incubated overnight at room temperature. The next day, strains to be tested were grown to OD620 of 0.5 and resuspended in PBS. Samples were sonicated on ice for 30 s in total (5 s on and 15 s off) using the Branson Sonifier 250 (Duty cycle 40%, output control 2). The antibody-coated plate was washed 5 times with wash buffer (10 mM Tris, pH 7.4, 0.02% NaN3, 150 mM NaCl, 0.05% Brij), and 100 μL of 2-fold serially diluted bacterial lysate was aliquoted and incubated for 2 h at RT. The cell lysate was removed, wells washed 3 times with wash buffer, incubated with 1% BSA in PBS for 1 h, and washed again 3 times. Then, 100 μL of CPS antibody (1:3,000 in 1% BSA/PBS; monoclonal against serotype 4 CPS, kindly provided by Moon Nahm, UAB) was applied and incubated for 24 h with gentle agitation at 4°C. The plates were then washed 5 times with wash buffer and incubated with goat antimouse antibody conjugated to alkaline phosphatase (Sigma-Aldrich; A3688-1 MI; 1:10,000 1% BSA/PBS) for 2 h at room temperature. The plate was washed 5 times before being developed with phosphatase substrate p-nitrophenyl phosphate (PNPP) (Thermo Scientific, product number 34047) for 20 min and read at OD405 on a Biotek H1 synergy plate reader.
Statistical analysis.
All statistical analyses were performed using GraphPad Prism (version 9.0) software (GraphPad Software, Inc., San Diego, CA). Unless otherwise specified, statistical differences were calculated using the Mann-Whitney U test (comparing two groups) or the Kruskal-Wallis test with Dunn’s postanalysis (comparing multiple groups).
Data availability.
The RNAseq data generated and statistical analysis performed are available in Table S1 in the supplemental material.
ACKNOWLEDGMENTS
We are grateful for the members of Zafar laboratory (Wake Forest School of Medicine), and Kimberly Walker (UNC Chapel Hill) for comments on the manuscript. This project was supported by startup funds provided by Wake Forest Baptist Medical Center and U.S. Public Health Service grant (R21AI154047) to M.A.Z.
We also acknowledge the support of the Wake Forest Baptist Comprehensive Cancer Center Cancer Genomics Shared Resource, supported by the National Cancer Institute’s Cancer Center Support Grant, award number P30CA012197.
Footnotes
Supplemental material is available online only.
Contributor Information
M. Ammar Zafar, Email: mzafar@wakehealth.edu.
Nancy E. Freitag, University of Illinois at Chicago
REFERENCES
- 1.Weiser JN, Ferreira DM, Paton JC. 2018. Streptococcus pneumoniae: transmission, colonization and invasion. Nat Rev Microbiol 16:355–367. 10.1038/s41579-018-0001-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.World Health Organization. 2007. Pneumococcal conjugate vaccine for childhood immunization–WHO position paper. Wkly Epidemiol Rec 82:93–104. [PubMed] [Google Scholar]
- 3.O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T, Dis HPGB, Hib and Pneumococcal Global Burden of Disease Study Team . 2009. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374:893–902. 10.1016/S0140-6736(09)61204-6. [DOI] [PubMed] [Google Scholar]
- 4.D'Mello A, Riegler AN, Martinez E, Beno SM, Ricketts TD, Foxman EF, Orihuela CJ, Tettelin H. 2020. An in vivo atlas of host-pathogen transcriptomes during Streptococcus pneumoniae colonization and disease. Proc Natl Acad Sci USA 117:33507–33518. 10.1073/pnas.2010428117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Shenoy AT, Brissac T, Gilley RP, Kumar N, Wang Y, Gonzalez-Juarbe N, Hinkle WS, Daugherty SC, Shetty AC, Ott S, Tallon LJ, Deshane J, Tettelin H, Orihuela CJ. 2017. Streptococcus pneumoniae in the heart subvert the host response through biofilm-mediated resident macrophage killing. PLoS Pathog 13:e1006582. 10.1371/journal.ppat.1006582. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Minhas V, Aprianto R, McAllister LJ, Wang H, David SC, McLean KT, Comerford I, McColl SR, Paton JC, Veening JW, Trappetti C. 2020. In vivo dual RNA-seq reveals that neutrophil recruitment underlies differential tissue tropism of Streptococcus pneumoniae. Commun Biol 3. 10.1038/s42003-020-1018-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Basset A, Wall E, Mitsi E, Deshusses C, Daly R, Pojar S, Reine J, Guerra-Assuncao JA, Denis B, Jochems SP, Heyderman R, Brown J, Lu YJ, Ferreira DM, Malley R. 2022. Targeted transcriptomic screen of pneumococcal genes expressed during murine and human infection. Infect Immun 90:e0017522. 10.1128/iai.00175-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Gomez-Mejia A, Gamez G, Hammerschmidt S. 2018. Streptococcus pneumoniae two-component regulatory systems: the interplay of the pneumococcus with its environment. Int J Med Microbiol 308:722–737. 10.1016/j.ijmm.2017.11.012. [DOI] [PubMed] [Google Scholar]
- 9.Jacob-Dubuisson F, Mechaly A, Betton JM, Antoine R. 2018. Structural insights into the signalling mechanisms of two-component systems. Nat Rev Microbiol 16:585–593. 10.1038/s41579-018-0055-7. [DOI] [PubMed] [Google Scholar]
- 10.Paterson GK, Blue CE, Mitchell TJ. 2006. Role of two-component systems in the virulence of Streptococcus pneumoniae. J Med Microbiol 55:355–363. 10.1099/jmm.0.46423-0. [DOI] [PubMed] [Google Scholar]
- 11.Gamez G, Castro A, Gomez-Mejia A, Gallego M, Bedoya A, Camargo M, Hammerschmidt S. 2018. The variome of pneumococcal virulence factors and regulators. BMC Genomics 19:10. 10.1186/s12864-017-4376-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.He LY, Le YJ, Guo Z, Li S, Yang XY. 2021. The role and regulatory network of the CiaRH two-component system in streptococcal species. Front Microbiol 12:693858. 10.3389/fmicb.2021.693858. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Reinoso-Vizcaino NM, Cian MB, Cortes PR, Olivero NB, Hernandez-Morfa M, Pinas GE, Badapanda C, Rathore A, Perez DR, Echenique J. 2020. The pneumococcal two-component system SirRH is linked to enhanced intracellular survival of Streptococcus pneumoniae in influenza-infected pulmonary cells. PLoS Pathog 16:e1008761. 10.1371/journal.ppat.1008761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Cortes PR, Pinas GE, Cian MB, Yandar N, Echenique J. 2015. Stress-triggered signaling affecting survival or suicide of Streptococcus pneumoniae. Int J Med Microbiol 305:157–169. 10.1016/j.ijmm.2014.12.002. [DOI] [PubMed] [Google Scholar]
- 15.Zafar MA, Wang Y, Hamaguchi S, Weiser JN. 2017. Host-to-host transmission of Streptococcus pneumoniae is driven by its inflammatory toxin, pneumolysin. Cell Host Microbe 21:73–83. 10.1016/j.chom.2016.12.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Zafar MA, Hammond AJ, Hamaguchi S, Wu WS, Kono M, Zhao LL, Weiser JN. 2019. Identification of pneumococcal factors affecting pneumococcal shedding shows that the dlt locus promotes inflammation and transmission. mBio 10. 10.1128/mBio.01032-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Zafar MA, Hamaguchi S, Zangari T, Cammer M, Weiser JN. 2017. Capsule type and amount affect shedding and transmission of streptococcus pneumoniae. mBio 8. 10.1128/mBio.00989-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Zangari T, Zafar MA, Lees JA, Abruzzo AR, Bee GCW, Weiser JN. 2021. Pneumococcal capsule blocks protection by immunization with conserved surface proteins. NPJ Vaccines 6:155. 10.1038/s41541-021-00413-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Rowe HM, Karlsson E, Echlin H, Chang TC, Wang L, van Opijnen T, Pounds SB, Schultz-Cherry S, Rosch JW. 2019. Bacterial factors required for transmission of Streptococcus pneumoniae in mammalian hosts. Cell Host Microbe 25:884–891.e6. 10.1016/j.chom.2019.04.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Andreassen PR, Trappetti C, Minhas V, Nielsen FD, Pakula K, Paton JC, Jorgensen MG. 2020. Host-glycan metabolism is regulated by a species-conserved two-component system in Streptococcus pneumoniae. PLoS Pathog 16:e1008332. 10.1371/journal.ppat.1008332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Philips BJ, Meguer JX, Redman J, Baker EH. 2003. Factors determining the appearance of glucose in upper and lower respiratory tract secretions. Intensive Care Med 29:2204–2210. 10.1007/s00134-003-1961-2. [DOI] [PubMed] [Google Scholar]
- 22.Buckwalter CM, King SJ. 2012. Pneumococcal carbohydrate transport: food for thought. Trends Microbiol 20:517–522. 10.1016/j.tim.2012.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Lillehoj EP, Kato K, Lu W, Kim KC. 2013. Cellular and molecular biology of airway mucins. Int Rev Cell Mol Biol 303:139–202. 10.1016/B978-0-12-407697-6.00004-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Zafar MA, Kono M, Wang Y, Zangari T, Weiser JN. 2016. Infant mouse model for the study of shedding and transmission during streptococcus pneumoniae monoinfection. Infect Immun 84:2714–2722. 10.1128/IAI.00416-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Bidossi A, Mulas L, Decorosi F, Colomba L, Ricci S, Pozzi G, Deutscher J, Viti C, Oggioni MR. 2012. A functional genomics approach to establish the complement of carbohydrate transporters in Streptococcus pneumoniae. PLoS One 7:e33320. 10.1371/journal.pone.0033320. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Plumptre CD, Eijkelkamp BA, Morey JR, Behr F, Counago RM, Ogunniyi AD, Kobe B, O'Mara ML, Paton JC, McDevitt CA. 2014. AdcA and AdcAII employ distinct zinc acquisition mechanisms and contribute additively to zinc homeostasis in Streptococcus pneumoniae. Mol Microbiol 91:834–851. 10.1111/mmi.12504. [DOI] [PubMed] [Google Scholar]
- 27.Loisel E, Chimalapati S, Bougault C, Imberty A, Gallet B, Di Guilmi AM, Brown J, Vernet T, Durmort C. 2011. Biochemical characterization of the histidine triad protein PhtD as a cell surface zinc-binding protein of pneumococcus. Biochemistry 50:3551–3558. 10.1021/bi200012f. [DOI] [PubMed] [Google Scholar]
- 28.Plumptre CD, Hughes CE, Harvey RM, Eijkelkamp BA, McDevitt CA, Paton JC. 2014. Overlapping functionality of the Pht proteins in zinc homeostasis of Streptococcus pneumoniae. Infect Immun 82:4315–4324. 10.1128/IAI.02155-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Khan MN, Sharma SK, Filkins LM, Pichichero ME. 2012. PcpA of Streptococcus pneumoniae mediates adherence to nasopharyngeal and lung epithelial cells and elicits functional antibodies in humans. Microbes Infect 14:1102–1110. 10.1016/j.micinf.2012.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Johnston JW, Briles DE, Myers LE, Hollingshead SK. 2006. Mn2+-dependent regulation of multiple genes in Streptococcus pneumoniae through PsaR and the resultant impact on virulence. Infect Immun 74:1171–1180. 10.1128/IAI.74.2.1171-1180.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Robb M, Hobbs JK, Woodiga SA, Shapiro-Ward S, Suits MD, McGregor N, Brumer H, Yesilkaya H, King SJ, Boraston AB. 2017. Molecular characterization of N-glycan degradation and transport in streptococcus pneumoniae and its contribution to virulence. PLoS Pathog 13:e1006090. 10.1371/journal.ppat.1006090. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Arslan P, Di Virgilio F, Beltrame M, Tsien RY, Pozzan T. 1985. Cytosolic Ca2+ homeostasis in Ehrlich and Yoshida carcinomas. A new, membrane-permeant chelator of heavy metals reveals that these ascites tumor cell lines have normal cytosolic free Ca2+. J Biol Chem 260:2719–2727. 10.1016/S0021-9258(18)89421-2. [DOI] [PubMed] [Google Scholar]
- 33.Brundage JF. 2006. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis 6:303–312. 10.1016/S1473-3099(06)70466-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Morens DM, Taubenberger JK, Fauci AS. 2008. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 198:962–970. 10.1086/591708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.McCullers JA. 2006. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 19:571–582. 10.1128/CMR.00058-05. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Weinberger DM, Simonsen L, Jordan R, Steiner C, Miller M, Viboud C. 2012. Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States. J Infect Dis 205:458–465. 10.1093/infdis/jir749. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Siegel SJ, Roche AM, Weiser JN. 2014. Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source. Cell Host Microbe 16:55–67. 10.1016/j.chom.2014.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Richard AL, Siegel SJ, Erikson J, Weiser JN. 2014. TLR2 signaling decreases transmission of Streptococcus pneumoniae by limiting bacterial shedding in an infant mouse Influenza A co-infection model. PLoS Pathog 10:e1004339. 10.1371/journal.ppat.1004339. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Short KR, Reading PC, Wang N, Diavatopoulos DA, Wijburg OL. 2012. Increased nasopharyngeal bacterial titers and local inflammation facilitate transmission of Streptococcus pneumoniae. mBio 3. 10.1128/mBio.00255-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Chen YY, Huang CT, Li SW, Pan YJ, Lin TL, Huang YY, Li TH, Yang YC, Gong YN, Hsieh YC. 2021. Bacterial factors required for Streptococcus pneumoniae coinfection with influenza A virus. J Biomed Sci 28:60. 10.1186/s12929-021-00756-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Hammond AJ, Binsker U, Aggarwal SD, Ortigoza MB, Loomis C, Weiser JN. 2021. Neuraminidase B controls neuraminidase A-dependent mucus production and evasion. PLoS Pathog 17:e1009158. 10.1371/journal.ppat.1009158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Zangari T, Ortigoza MB, Lokken-Toyli KL, Weiser JN. 2021. Type I interferon signaling is a common factor driving Streptococcus pneumoniae and influenza a virus shedding and transmission. mBio 12. 10.1128/mBio.03589-20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Binsker U, Lees JA, Hammond AJ, Weiser JN. 2020. Immune exclusion by naturally acquired secretory IgA against pneumococcal pilus-1. J Clin Invest 130:927–941. 10.1172/JCI132005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Hava DL, Camilli A. 2002. Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors. Mol Microbiol 45:1389–1406. [PMC free article] [PubMed] [Google Scholar]
- 45.Throup JP, Koretke KK, Bryant AP, Ingraham KA, Chalker AF, Ge Y, Marra A, Wallis NG, Brown JR, Holmes DJ, Rosenberg M, Burnham MK. 2000. A genomic analysis of two-component signal transduction in Streptococcus pneumoniae. Mol Microbiol 35:566–576. 10.1046/j.1365-2958.2000.01725.x. [DOI] [PubMed] [Google Scholar]
- 46.Waldron KJ, Rutherford JC, Ford D, Robinson NJ. 2009. Metalloproteins and metal sensing. Nature 460:823–830. 10.1038/nature08300. [DOI] [PubMed] [Google Scholar]
- 47.Fischer Walker C, Black RE. 2004. Zinc and the risk for infectious disease. Annu Rev Nutr 24:255–275. 10.1146/annurev.nutr.23.011702.073054. [DOI] [PubMed] [Google Scholar]
- 48.Meydani SN, Barnett JB, Dallal GE, Fine BC, Jacques PF, Leka LS, Hamer DH. 2007. Serum zinc and pneumonia in nursing home elderly. Am J Clin Nutr 86:1167–1173. 10.1093/ajcn/86.4.1167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Carpentieri U, Smith L, Daeschner CW, 3rd, Haggard ME. 1983. Neutrophils and zinc in infection-prone children with sickle cell disease. Pediatrics 72:88–92. 10.1542/peds.72.1.88. [DOI] [PubMed] [Google Scholar]
- 50.Eijkelkamp BA, Morey JR, Neville SL, Tan A, Pederick VG, Cole N, Singh PP, Ong CY, Gonzalez de Vega R, Clases D, Cunningham BA, Hughes CE, Comerford I, Brazel EB, Whittall JJ, Plumptre CD, McColl SR, Paton JC, McEwan AG, Doble PA, McDevitt CA. 2019. Dietary zinc and the control of Streptococcus pneumoniae infection. PLoS Pathog 15:e1007957. 10.1371/journal.ppat.1007957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Strand TA, Hollingshead SK, Julshamn K, Briles DE, Blomberg B, Sommerfelt H. 2003. Effects of zinc deficiency and pneumococcal surface protein a immunization on zinc status and the risk of severe infection in mice. Infect Immun 71:2009–2013. 10.1128/IAI.71.4.2009-2013.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Maares M, Keil C, Straubing S, Robbe-Masselot C, Haase H. 2020. Zinc deficiency disturbs mucin expression, O-glycosylation and secretion by intestinal goblet cells. Int J Mol Sci 21. 10.3390/ijms21176149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Valavi E, Hakimzadeh M, Shamsizadeh A, Aminzadeh M, Alghasi A. 2011. The efficacy of zinc supplementation on outcome of children with severe pneumonia. A randomized double-blind placebo-controlled clinical trial. Indian J Pediatr 78:1079–1084. 10.1007/s12098-011-0458-1. [DOI] [PubMed] [Google Scholar]
- 54.Bhutta ZA, Black RE, Brown KH, Gardner JM, Gore S, Hidayat A, Khatun F, Martorell R, Ninh NX, Penny ME, Rosado JL, Roy SK, Ruel M, Sazawal S, Shankar A. 1999. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group. J Pediatr 135:689–697. 10.1016/S0022-3476(99)70086-7. [DOI] [PubMed] [Google Scholar]
- 55.Lassi ZS, Moin A, Bhutta ZA. 2016. Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev 12:CD005978. 10.1002/14651858.CD005978.pub3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.McDevitt CA, Ogunniyi AD, Valkov E, Lawrence MC, Kobe B, McEwan AG, Paton JC. 2011. A molecular mechanism for bacterial susceptibility to zinc. PLoS Pathog 7:e1002357. 10.1371/journal.ppat.1002357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Shafeeq S, Kuipers OP, Kloosterman TG. 2013. The role of zinc in the interplay between pathogenic streptococci and their hosts. Mol Microbiol 88:1047–1057. 10.1111/mmi.12256. [DOI] [PubMed] [Google Scholar]
- 58.Begg SL, Eijkelkamp BA, Luo Z, Couñago RM, Morey JR, Maher MJ, Ong C-lY, McEwan AG, Kobe B, O’Mara ML, Paton JC, McDevitt CA. 2015. Dysregulation of transition metal ion homeostasis is the molecular basis for cadmium toxicity in Streptococcus pneumoniae. Nat Commun 6. 10.1038/ncomms7418. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Corbin BD, Seeley EH, Raab A, Feldmann J, Miller MR, Torres VJ, Anderson KL, Dattilo BM, Dunman PM, Gerads R, Caprioli RM, Nacken W, Chazin WJ, Skaar EP. 2008. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319:962–965. 10.1126/science.1152449. [DOI] [PubMed] [Google Scholar]
- 60.Conrad ME, Umbreit JN, Moore EG. 1991. A role for mucin in the absorption of inorganic iron and other metal cations. A study in rats. Gastroenterology 100:129–136. 10.1016/0016-5085(91)90592-9. [DOI] [PubMed] [Google Scholar]
- 61.Zalewski PD, Truong-Tran AQ, Grosser D, Jayaram L, Murgia C, Ruffin RE. 2005. Zinc metabolism in airway epithelium and airway inflammation: basic mechanisms and clinical targets. A review. Pharmacol Ther 105:127–149. 10.1016/j.pharmthera.2004.09.004. [DOI] [PubMed] [Google Scholar]
- 62.Ogunniyi AD, Grabowicz M, Mahdi LK, Cook J, Gordon DL, Sadlon TA, Paton JC. 2009. Pneumococcal histidine triad proteins are regulated by the Zn2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H. FASEB J 23:731–738. 10.1096/fj.08-119537. [DOI] [PubMed] [Google Scholar]
- 63.Hendriksen WT, Bootsma HJ, Estevao S, Hoogenboezem T, de Jong A, de Groot R, Kuipers OP, Hermans PWM. 2008. CodY of Streptococcus pneumoniae: Link between nutritional gene regulation and colonization. J Bacteriol 190:590–601. 10.1128/JB.00917-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Kloosterman TG, Witwicki RM, van der Kooi-Pol MM, Bijlsma JJ, Kuipers OP. 2008. Opposite effects of Mn2+ and Zn2+ on PsaR-mediated expression of the virulence genes pcpA, prtA, and psaBCA of Streptococcus pneumoniae. J Bacteriol 190:5382–5393. 10.1128/JB.00307-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Kaur R, Casey JR, Pichichero ME. 2011. Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children. Pediatr Infect Dis J 30:645–650. 10.1097/INF.0b013e31821c2d8b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Pittet LA, Hall-Stoodley L, Rutkowski MR, Harmsen AG. 2010. Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae. Am J Respir Cell Mol Biol 42:450–460. 10.1165/rcmb.2007-0417OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Ortigoza MB, Blaser SB, Zafar MA, Hammond AJ, Weiser JN. 2018. An infant mouse model of influenza virus transmission demonstrates the role of virus-specific shedding, humoral immunity, and sialidase expression by colonizing Streptococcus pneumoniae. mBio 9. 10.1128/mBio.02359-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Short KR, Habets MN, Hermans PW, Diavatopoulos DA. 2012. Interactions between Streptococcus pneumoniae and influenza virus: a mutually beneficial relationship? Future Microbiol 7:609–624. 10.2217/fmb.12.29. [DOI] [PubMed] [Google Scholar]
- 69.Pettigrew MM, Marks LR, Kong Y, Gent JF, Roche-Hakansson H, Hakansson AP. 2014. Dynamic changes in the Streptococcus pneumoniae transcriptome during transition from biofilm formation to invasive disease upon influenza a virus infection. Infect Immun 82:4607–4619. 10.1128/IAI.02225-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.US Department of Health and Human Services. 2015. Public Health Service policy on humane care and use of laboratory animals. US Department of Health and Human Services, Washington, DC. [Google Scholar]
- 71.Worlein JM, Baker K, Bloomsmith M, Coleman K, Koban TL. 2011. The eighth edition of the guide for the care and use of laboratory animals (2011); implications for behavioral management. American J Primatology 73:98–98. [Google Scholar]
- 72.Sung CK, Li H, Claverys JP, Morrison DA. 2001. An rpsL cassette, janus, for gene replacement through negative selection in Streptococcus pneumoniae. Appl Environ Microbiol 67:5190–5196. 10.1128/AEM.67.11.5190-5196.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114–2120. 10.1093/bioinformatics/btu170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Langmead B, Salzberg SL. 2012. Fast gapped-read alignment with Bowtie 2. Nat Methods 9:357–359. 10.1038/nmeth.1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Liao Y, Smyth GK, Shi W. 2014. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30:923–930. 10.1093/bioinformatics/btt656. [DOI] [PubMed] [Google Scholar]
- 76.Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. 10.1186/s13059-014-0550-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Lemon JK, Miller MR, Weiser JN. 2015. Sensing of interleukin-1 cytokines during Streptococcus pneumoniae colonization contributes to macrophage recruitment and bacterial clearance. Infect Immun 83:3204–3212. 10.1128/IAI.00224-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Siegel SJ, Tamashiro E, Weiser JN. 2015. Clearance of pneumococcal colonization in infants is delayed through altered macrophage trafficking. PLoS Pathog 11:e1005004. 10.1371/journal.ppat.1005004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Kaur R, Surendran N, Ochs M, Pichichero ME. 2014. Human antibodies to PhtD, PcpA, and Ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae. Infect Immun 82:5069–5075. 10.1128/IAI.02124-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Walker MM, Novak L, Widener R, Grubbs JA, King J, Hale JY, Ochs MM, Myers LE, Briles DE, Deshane J. 2016. PcpA promotes higher levels of infection and modulates recruitment of myeloid-derived suppressor cells during pneumococcal pneumonia. J Immunol 196:2239–2248. 10.4049/jimmunol.1402518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Brown LR, Gunnell SM, Cassella AN, Keller LE, Scherkenbach LA, Mann B, Brown MW, Hill R, Fitzkee NC, Rosch JW, Tuomanen EI, Thornton JA. 2016. AdcAII of Streptococcus pneumoniae affects pneumococcal invasiveness. PLoS One 11:e0146785. 10.1371/journal.pone.0146785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Andre GO, Converso TR, Politano WR, Ferraz LF, Ribeiro ML, Leite LC, Darrieux M. 2017. Role of Streptococcus pneumoniae proteins in evasion of complement-mediated immunity. Front Microbiol 8:224. 10.3389/fmicb.2017.00224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Khan MN, Pichichero ME. 2012. Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans. Vaccine 30:2900–2907. 10.1016/j.vaccine.2012.02.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Novak R, Braun JS, Charpentier E, Tuomanen E. 1998. Penicillin tolerance genes of Streptococcus pneumoniae: the ABC-type manganese permease complex Psa. Mol Microbiol 29:1285–1296. 10.1046/j.1365-2958.1998.01016.x. [DOI] [PubMed] [Google Scholar]
- 85.Brooks LRK, Mias GI. 2018. Streptococcus pneumoniae's virulence and host immunity: aging, diagnostics, and prevention. Front Immunol 9:1366. 10.3389/fimmu.2018.01366. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Polissi A, Pontiggia A, Feger G, Altieri M, Mottl H, Ferrari L, Simon D. 1998. Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect Immun 66:5620–5629. 10.1128/IAI.66.12.5620-5629.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Chen H, Ma Y, Yang J, O'Brien CJ, Lee SL, Mazurkiewicz JE, Haataja S, Yan JH, Gao GF, Zhang JR. 2007. Genetic requirement for pneumococcal ear infection. PLoS One 3:e2950. 10.1371/journal.pone.0002950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Hui FM, Morrison DA. 1993. Identification of a purC gene from Streptococcus pneumoniae. J Bacteriol 175:6364–6367. 10.1128/jb.175.19.6364-6367.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Song XM, Connor W, Hokamp K, Babiuk LA, Potter AA. 2009. Transcriptome studies on Streptococcus pneumoniae, illustration of early response genes to THP-1 human macrophages. Genomics 93:72–82. 10.1016/j.ygeno.2008.09.008. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Tables S2 and S3 and Fig. S1 to S4. Download iai.00375-22-s0001.pdf, PDF file, 1.5 MB (1.5MB, pdf)
Table S1. Download iai.00375-22-s0002.xlsx, XLSX file, 0.2 MB (246.6KB, xlsx)
Data Availability Statement
The RNAseq data generated and statistical analysis performed are available in Table S1 in the supplemental material.
